Pages that link to "Q37127500"
Jump to navigation
Jump to search
The following pages link to Neuronal activity enhances tau propagation and tau pathology in vivo. (Q37127500):
Displaying 50 items.
- Roles of tau protein in health and disease (Q33559303) (← links)
- Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies (Q33714234) (← links)
- Considerations for Experimental Animal Models of Concussion, Traumatic Brain Injury, and Chronic Traumatic Encephalopathy-These Matters Matter (Q33747407) (← links)
- Stem cell models of Alzheimer's disease: progress and challenges (Q33796378) (← links)
- Tau secretion is correlated to an increase of Golgi dynamics. (Q36383795) (← links)
- Exosomes, an Unmasked Culprit in Neurodegenerative Diseases. (Q37614565) (← links)
- Protein misfolding in neurodegenerative diseases: implications and strategies (Q37697832) (← links)
- Multinodular and vacuolating neuronal tumors in epilepsy: dysplasia or neoplasia? (Q38611971) (← links)
- Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation. (Q38684346) (← links)
- Local Somatodendritic Translation and Hyperphosphorylation of Tau Protein Triggered by AMPA and NMDA Receptor Stimulation. (Q38752742) (← links)
- Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals (Q38896981) (← links)
- The road to restoring neural circuits for the treatment of Alzheimer's disease (Q39004340) (← links)
- The activities of amyloids from a structural perspective (Q39004351) (← links)
- Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses (Q39043782) (← links)
- The prion model for progression and diversity of neurodegenerative diseases (Q39151589) (← links)
- Epileptic activity in Alzheimer's disease: causes and clinical relevance (Q39192571) (← links)
- A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies (Q39270980) (← links)
- Prion-like Spreading in Tauopathies (Q39307688) (← links)
- Propagation of Tau aggregates (Q39338832) (← links)
- Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease (Q39339952) (← links)
- Modeling tau pathology in human stem cell derived neurons (Q39353869) (← links)
- Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's Disease. (Q39419112) (← links)
- The relevance of contact-independent cell-to-cell transfer of TDP-43 and SOD1 in amyotrophic lateral sclerosis (Q39437151) (← links)
- The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases. (Q39445835) (← links)
- Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons. (Q40321151) (← links)
- Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early Alzheimer's disease (Q41052224) (← links)
- Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia (Q41706435) (← links)
- Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus (Q42361161) (← links)
- Perspective Insights of Exosomes in Neurodegenerative Diseases: A Critical Appraisal (Q42369812) (← links)
- Tunneling nanotubes: A possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases. (Q42369895) (← links)
- Distinct Phases of Tau, Amyloid, and Functional Connectivity in Healthy Older Adults. (Q46142950) (← links)
- ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins. (Q46180253) (← links)
- Extracellular Tau and Its Potential Role in the Propagation of Tau Pathology (Q47139411) (← links)
- Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer's disease-like pathology (Q47153423) (← links)
- What is the evidence that tau pathology spreads through prion-like propagation? (Q47163825) (← links)
- Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease. (Q47296152) (← links)
- Prying into the Prion Hypothesis for Parkinson's Disease (Q47665674) (← links)
- Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain. (Q47687675) (← links)
- Dorsolateral prefrontal cortex GABA deficit in older adults with sleep-disordered breathing. (Q47688951) (← links)
- Tau-based therapies in neurodegeneration: opportunities and challenges (Q47689697) (← links)
- Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse model. (Q47844754) (← links)
- High-glucose induces tau hyperphosphorylation through activation of TLR9-P38MAPK pathway (Q47959867) (← links)
- Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals (Q48102802) (← links)
- Computational modelling of pathogenic protein spread in neurodegenerative diseases (Q48105230) (← links)
- MEG biomarker of Alzheimer's disease: Absence of a prefrontal generator during auditory sensory gating. (Q48116946) (← links)
- Dual Mechanism of Toxicity for Extracellular Injection of Tau Oligomers versus Monomers in Human Tau Mice (Q48215146) (← links)
- Tau and amyloid β proteins distinctively associate to functional network changes in the aging brain (Q48234728) (← links)
- Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline (Q48284478) (← links)
- Is epilepsy a curable neurodegenerative disease? (Q48553547) (← links)
- A method for inferring regional origins of neurodegeneration (Q50161290) (← links)